Mark Zuckerberg-Backed AI Startup Takes Over Parkinson’s Treatment From the Maker of Ozempic

4 months ago 24
Add to circle
Cellular Intelligence just acquired the rights to an experimental Parkinson’s cell therapy from Novo Nordisk.
Read Entire Article
  1. Homepage
  2. Technology
  3. Mark Zuckerberg-Backed AI Startup Takes Over Parkinson’s Treatment From the Maker of Ozempic

Related

How hyperscalers like Amazon, Microsoft, and Google are siding with consumers on data center power costs and sweetening offers for communities to gain support (Ann Davis Vaughan/The Information)

How hyperscalers like Amazon, Microsoft, and Google are sidi...

42 minutes ago 0
Show HN: 1080p is 920px tall – 1k real browser viewports

Show HN: 1080p is 920px tall – 1k real browser viewports

1 hour ago 0
Should US Open-Weight AI Labs 'Distill' Frontier Models Too?

Should US Open-Weight AI Labs 'Distill' Frontier Models Too?...

1 hour ago 0